Welcome to Advanced Search

Slc22a1-KO(SD)

Strain Name：SD-Slc22a1^em1Smoc Strain State：Embryo cryopreservation | Cat. NO.：NR-KO-190009

Exon 2-3 of Slc22a1(Oct1) gene was deleted to generate Slc22a1(Oct1) knockout rat.

Nr1i3-KO(SD)

Strain Name：SD-Nr1i3^em1Smoc Strain State：Embryo cryopreservation | Cat. NO.：NR-KO-190008

Exon 2 of Nr1i3 gene was deleted to generate Nr1i3 knockout rat.

Abcg2-KO(SD)

Strain Name：SD-Abcg2^em1Smoc Strain State：Embryo cryopreservation | Cat. NO.：NR-KO-190007

Exon 4-5 of Abcg2 gene was deleted to generate Abcg2 knockout rat.

Abcc2-KO(SD)

Strain Name：SD-Abcc2^em1Smoc Strain State：Embryo cryopreservation | Cat. NO.：NR-KO-200002

Exon 4-6 of Abcc2 gene was deleted to generate Abcc2 knockout rat.

hFcRn(SD)

Strain Name：SD-Fcgrt^{em1(hFCGRT)Smoc} Strain State：Repository Live | Cat. NO.：NR-HU-200002
Validation Data：Presence

The endogenous rat Fcgrt gene was replaced by human FCGRT gene.

RPB5-Mediating Protein Promotes Cholangiocarcinoma Tumorigenesis and Drug Resistance by Competing With NRF2 for KEAP1...

Model Organisms：Mouse Product & Service：Rpb5 Research field：Cholangiocarcinoma

Lithium, an anti-psychotic drug, greatly enhances the generation of induced pluripotent stem cells

Model Organisms：小鼠 Product & Service：- Research field：Embryonic development

Lithium iPSCs 诱导性胚胎干细胞

Breaking Spatiotemporal Barriers of Immunogenic Chemotherapy via an Endoplasmic Reticulum Membrane-Assisted Liposomal...

Model Organisms：小鼠 Product & Service：huHSC-(M-NSG) Research field：antitumor immunity

Advancing Cancer Therapy: Harnessing In Vivo Tumor Models for Breakthrough Drug Development

Cancer therapy advancements In vivo tumor models Preclinical cancer research Drug development in oncology Gene-modified cell lines Immuno-oncology Tumor modeling for drug discovery Cancer drug development Animal modeling services Cancer drug preclinical models

Join us for an insightful webinar exploring the critical role of in vivo tumor models in advancing cancer drug therapy. We will provide an overview of the diverse tumor models developed by our company, highlighting case studies demonstrating their effectiveness in preclinical cancer research. The session will delve into the comprehensive use of gene-modified cell lines and genetically modified spontaneous mouse models, showcasing their application in mimicking human cancer biology. We will conclude with a brief introduction to our company and our commitment to accelerating cancer drug development through innovative animal modeling services.

Join Our Webinar: Applications of Humanized Mouse Models in Preclinical Research

Humanized mouse models preclinical research targeted therapies webinar oncology drug development preclinical therapeutic advancements immune system models animal modeling services

Join GenoBioTX's webinar on July 25th to explore the latest advancements in humanized mouse models for preclinical research. Learn how these models are transforming targeted therapy development across various diseases. Featuring expert insights from Dr. Derek Reznik, discover the generation and application of humanized immune system models in oncology drug development. Don't miss this opportunity to enhance your knowledge in cutting-edge preclinical therapeutic advancements. Register now!